Astex Pharmaceuticals, Inc
DelistedCIK 919722fmd_1RKG9F6R09GVYW8FVXRTRHGDP9Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2013, 14 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|
| Total revenues | 41 | 53 | 67 | 83 |
| Research and development | 30 | 28 | 44 | 60 |
| Selling, general and administrative | 9 | 9 | 17 | 16 |
| Total operating expenses | 38 | 37 | 65 | 90 |
| Operating income | 3 | 16 | 2 | (7) |
| Interest and investment income | 1 | 0 | 0 | 0 |
| Other non-operating income (expense) | – | 0 | (0) | 0 |
| Income before taxes | 4 | 16 | 2 | (5) |
| Income tax expense | (1) | 0 | (3) | (13) |
| Net income from continuing operations | 5 | 16 | 6 | 8 |
| Net income to common shareholders | 5 | 16 | 6 | 8 |